Similar articles

• Intestinal mast cell responses in idiopathic inflammatory bowel disease. Histamine release from human intestinal mast cells in response to gut epithelial proteins.

  Fox CC, Lichtenstein LM, Roche JK. Fox CC, et al. Dig Dis Sci. 1993 Jun;38(6):1105-12. doi: 10.1007/BF01295728. Dig Dis Sci. 1993. PMID: 7685262
• Similarity in the metabolic profile in macroscopically involved and un-involved colonic mucosa in patients with inflammatory bowel disease: an in vitro proton ((1)H) MR spectroscopy study.

  Sharma U, Singh RR, Ahuja V, Makharia GK, Jagannathan NR. Sharma U, et al. Magn Reson Imaging. 2010 Sep;28(7):1022-9. doi: 10.1016/j.mri.2010.03.039. Epub 2010 Apr 24. Magn Reson Imaging. 2010. PMID: 20418044
• Innate immunity and colonic inflammation: enhanced expression of epithelial alpha-defensins.

  Wehkamp J, Schwind B, Herrlinger KR, Baxmann S, Schmidt K, Duchrow M, Wohlschläger C, Feller AC, Stange EF, Fellermann K. Wehkamp J, et al. Dig Dis Sci. 2002 Jun;47(6):1349-55. doi: 10.1023/a:1015334917273. Dig Dis Sci. 2002. PMID: 12064812
• Butyrate utilization by the colonic mucosa in inflammatory bowel diseases: a transport deficiency.

  Thibault R, Blachier F, Darcy-Vrillon B, de Coppet P, Bourreille A, Segain JP. Thibault R, et al. Inflamm Bowel Dis. 2010 Apr;16(4):684-95. doi: 10.1002/ibd.21108. Inflamm Bowel Dis. 2010. PMID: 19774643 Review.
• Peroxisome proliferator-activated receptor gamma in the colon: inflammation and innate antimicrobial immunity.

  Speca S, Dubuquoy L, Desreumaux P. Speca S, et al. J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S23-7. doi: 10.1097/MCG.0000000000000253. J Clin Gastroenterol. 2014. PMID: 25291120 Review.